Expand raw payload
{
"buyer": {
"id": "GB-NHS-RX3",
"name": "TEES, ESK AND WEAR VALLEYS NHS FOUNDATION TRUST"
},
"date": "2025-11-05T11:06:18Z",
"id": "071173-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05d40b",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Darlington",
"postalCode": "DL22TS",
"region": "UKC13",
"streetAddress": "Trust Headquarters, West Park Hospital, Edward Pease Way"
},
"contactPoint": {
"email": "jemma.amer1@nhs.net",
"name": "Jemma",
"telephone": "+44 7867537014"
},
"details": {
"url": "http://www.TEWV.nhs.uk"
},
"id": "GB-NHS-RX3",
"identifier": {
"id": "RX3",
"legalName": "TEES, ESK AND WEAR VALLEYS NHS FOUNDATION TRUST",
"scheme": "GB-NHS"
},
"name": "TEES, ESK AND WEAR VALLEYS NHS FOUNDATION TRUST",
"roles": [
"buyer"
]
}
],
"tag": [
"tenderUpdate"
],
"tender": {
"amendments": [
{
"description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice under direct award A - no alternative suitable provider. \nThis contract has been awarded under the Health Care Services (Provider Selection Regime)\nRegulations 2023. For the avoidance of doubt, the provisions of the Public Contracts\nRegulations 2015 do not apply to this award.\nThe decision makers where:\nBrian Cranna - Director of Operations and Transformation\nPage 4 to 5\nNorth Yorkshire and York Care Group(30/09/25), Jamie Todd - Director of Operations \u0026\nTransformation\nDTVF CAMHS, Adult Mental Health and Ridgeway Secure Inpatient Services\nCare Group (30/09/25), Mel Woodcock - General Manager \nNorth Yorkshire, York \u0026 Selby CAMHS \u0026 LD Services (30/09/25), James Graham - \nGeneral Manager Durham and Tees Valley Community CAMHS (30/09/25) Steven Smith\nand Claire Bestford Principle Finance Business Partners NYY and DTV. (30/09/25)\nLiz Romaniak - Director of Finance, Estate and facilities - (20/10/25)\nNo Conflicts of interest where identified or declared. \nQbtech Ltd is the sole provider of QbTest, the only FDA Cleared, EMA registered \nand CE Marked medical device available in the UK to objectively measure\nHyperactivity, Inattention and Impulsivity. QbTest is cleared for use as an aid in the \nassessment and treatment evaluation of ADHD for those aged 6-60 years old.\nDetails of the FDA Clearances are: To aid in the clinical assessment of ADHD in\nchildren (K040894); To aid in the clinical assessment of ADHD in adolescents and \nadults (K122149); and: To aid in the evaluation of treatment interventions in patients \nwith ADHD (K133382). QbTest is the only ADHD test with NHS cost-efficiency",
"id": "1"
}
],
"classification": {
"description": "Health and social work services",
"id": "85000000",
"scheme": "CPV"
},
"description": "The Qbtech system QbTest offers an objective method for measuring the three core signs of ADHD \n- hyperactivity, inattention and impulsivity - in children, adolescents and adults. The test system is \nused to support diagnosis and to show response to and progress of treatment.",
"id": "ocds-h6vhtk-05d40b",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"mainProcurementCategory": "services",
"title": "PSR Direct Award A Notice - CAMHS ADHD Assessment tool"
}
}